A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The study is investigating efficacy, safety and tolerability of DNA-damage Response Agents (or Combinations), in participants with advanced/metastatic solid malignancies whose tumours contain molecular alterations
Epistemonikos ID: 452f3f2391480523150ca50e73f11e516c535a63
First added on: Oct 02, 2023